Lisa Maria Lucia Pham

Title: Innovations by Lisa Maria Lucia Pham

Introduction

Lisa Maria Lucia Pham is an accomplished inventor based in San Mateo, CA. She has made significant contributions to the field of pharmaceuticals, particularly in developing methods to counteract the cardiotoxic effects of chemotherapy. With a total of 4 patents to her name, her work is paving the way for safer cancer treatments.

Latest Patents

One of her latest patents focuses on pharmaceutical compositions and methods for countering chemotherapy-induced cardiotoxicity. This disclosure provides innovative methods and pharmaceutical compositions aimed at reducing or eliminating cardiotoxicity, especially that induced by cancer treatments. The methods often involve administering protective agents such as myricetin, tricetin, robinetin, ficetin, vitexin, quercetin, dihydrorobinetin, kaempferol, and others in conjunction with cancer drugs. These compositions may also include co-formulations of protective agents with anthracycline drugs, enhancing the safety and efficacy of cancer therapies.

Career Highlights

Throughout her career, Lisa has worked with notable companies such as Auransa Inc. and Sct II LLC. Her experience in these organizations has contributed to her expertise in pharmaceutical innovations and research.

Collaborations

Lisa has collaborated with esteemed colleagues, including Christopher G. Armstrong and Kevin J. Kim. These partnerships have further enriched her research and development efforts in the pharmaceutical field.

Conclusion

Lisa Maria Lucia Pham is a pioneering inventor whose work is making a significant impact in the realm of cancer treatment. Her innovative approaches to reducing chemotherapy-induced cardiotoxicity are vital for improving patient outcomes.